enrasentan has been researched along with Heart Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerrigter, G; Burnett, JC | 1 |
| Barlow, MM; Cleland, JG; Dargie, HJ; Groenning, BA; Grothues, F; Pennell, DJ; Prasad, SK; Smith, GC | 1 |
| Abraham, WT; Lamba, S; Suresh, DP | 1 |
| Clark, A; Cleland, JG; Crabbe, S; Ford, S; Houghton, T; Louis, A; Thackray, S | 1 |
3 review(s) available for enrasentan and Heart Failure
| Article | Year |
|---|---|
Endothelin in neurohormonal activation in heart failure.
Topics: Animals; Carboxylic Acids; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Heart; Heart Failure; Humans; Indans; Neurotransmitter Agents; Pyridines; Tetrazoles; Vasodilator Agents | 2003 |
New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.
Topics: Bosentan; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Humans; Indans; Peptides, Cyclic; Prognosis; Pyridines; Pyrimidines; Receptors, Endothelin; Sulfonamides; Treatment Outcome | 2000 |
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol; Cholesterol; Cytokines; Endothelins; Heart Failure; Humans; Indans; Injections, Intravenous; Myocardial Infarction; Propanolamines; Pyridines; Tetrazoles; United States; Vasodilator Agents | 2001 |
2 trial(s) available for enrasentan and Heart Failure
| Article | Year |
|---|---|
Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Carboxylic Acids; Disease Progression; Enalapril; Female; Heart Failure; Humans; Indans; Magnetic Resonance Angiography; Male; Middle Aged; Neurotransmitter Agents; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2006 |
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cachexia; Carbazoles; Carboxylic Acids; Carvedilol; Cholesterol; Cytokines; Endothelins; Heart Failure; Humans; Indans; Injections, Intravenous; Myocardial Infarction; Propanolamines; Pyridines; Tetrazoles; United States; Vasodilator Agents | 2001 |
1 other study(ies) available for enrasentan and Heart Failure
| Article | Year |
|---|---|
Enrasetan. SB 217242.
Topics: Animals; Carboxylic Acids; Clinical Trials as Topic; Drugs, Investigational; Endothelin Receptor Antagonists; Heart Failure; Indans; Myocardial Ischemia; Nervous System Diseases; Vascular Diseases | 1999 |